These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 30976361)

  • 1. Development of novel and safer anti-breast cancer agents, SS1020 and SS5020, based on a fundamental carcinogenic research.
    Okamoto Y; Shibutani S
    Genes Environ; 2019; 41():9. PubMed ID: 30976361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-breast cancer potential of SS1020, a novel antiestrogen lacking estrogenic and genotoxic actions.
    Laxmi YR; Liu X; Suzuki N; Kim SY; Okamoto K; Kim HJ; Zhang G; Chen JJ; Okamoto Y; Shibutani S
    Int J Cancer; 2010 Oct; 127(7):1718-26. PubMed ID: 20073065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-breast cancer potential of SS5020, a novel benzopyran antiestrogen.
    Suzuki N; Liu X; Laxmi YR; Okamoto K; Kim HJ; Zhang G; Chen JJ; Okamoto Y; Shibutani S
    Int J Cancer; 2011 Feb; 128(4):974-82. PubMed ID: 20824696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotoxic mechanism of tamoxifen in developing endometrial cancer.
    Kim SY; Suzuki N; Laxmi YR; Shibutani S
    Drug Metab Rev; 2004 May; 36(2):199-218. PubMed ID: 15237851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formation of tamoxifen-DNA adducts via O-sulfonation, not O-acetylation, of alpha-hydroxytamoxifen in rat and human livers.
    Kim SY; Laxmi YR; Suzuki N; Ogura K; Watabe T; Duffel MW; Shibutani S
    Drug Metab Dispos; 2005 Nov; 33(11):1673-8. PubMed ID: 16099924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formation of tamoxifen-DNA adducts in human endometrial explants exposed to alpha-hydroxytamoxifen.
    Kim SY; Suzuki N; Laxmi YR; McGarrigle BP; Olson JR; Sharma M; Sharma M; Shibutani S
    Chem Res Toxicol; 2005 May; 18(5):889-95. PubMed ID: 15892583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of lower genotoxicity of toremifene compared with tamoxifen.
    Shibutani S; Ravindernath A; Terashima I; Suzuki N; Laxmi YR; Kanno Y; Suzuki M; Apak TI; Sheng JJ; Duffel MW
    Cancer Res; 2001 May; 61(10):3925-31. PubMed ID: 11358807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA adduct formation and mutant induction in Sprague-Dawley rats treated with tamoxifen and its derivatives.
    Gamboa da Costa G; McDaniel-Hamilton LP; Heflich RH; Marques MM; Beland FA
    Carcinogenesis; 2001 Aug; 22(8):1307-15. PubMed ID: 11470763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Random nuclear p53 overexpression pattern in tamoxifen-mediated endometrial carcinoma.
    Kuwashima Y; Kurosumi M; Kobayashi Y; Tanuma J; Suemasu K; Higashi Y; Kasamatsu T; Shiromizu K; Kishi K
    Int J Gynecol Pathol; 1998 Apr; 17(2):135-9. PubMed ID: 9553810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of tamoxifen--DNA adducts in leukocytes from breast cancer patients treated with tamoxifen.
    Umemoto A; Monden Y; Lin CX; Abdul-Momen M; Ueyama Y; Komaki K; Laxmi YR; Shibutani S
    Chem Res Toxicol; 2004 Dec; 17(12):1577-83. PubMed ID: 15606132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the new selective estrogen receptor modulator LY353381.HCl (Arzoxifene) on human endometrial cancer growth in athymic mice.
    Dardes RC; Bentrem D; O'Regan RM; Schafer JM; Jordan VC
    Clin Cancer Res; 2001 Dec; 7(12):4149-55. PubMed ID: 11751515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tamoxifen: evidence by 32P-postlabeling and use of metabolic inhibitors for two distinct pathways leading to mouse hepatic DNA adduct formation and identification of 4-hydroxytamoxifen as a proximate metabolite.
    Randerath K; Moorthy B; Mabon N; Sriram P
    Carcinogenesis; 1994 Oct; 15(10):2087-94. PubMed ID: 7955037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiestrogens and the formation of DNA damage in rats: a comparison.
    Kim SY; Suzuki N; Laxmi YR; Umemoto A; Matsuda T; Shibutani S
    Chem Res Toxicol; 2006 Jun; 19(6):852-8. PubMed ID: 16780365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of 8-hydroxy-2'-deoxguanosine in DNA by microsomal activation of tamoxifen and 4-hydroxytamoxifen.
    Ye Q; Bodell WJ
    Carcinogenesis; 1996 Aug; 17(8):1747-50. PubMed ID: 8761436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrospray ionization-tandem mass spectrometry and 32P-postlabeling analyses of tamoxifen-DNA adducts in humans.
    Beland FA; Churchwell MI; Doerge DR; Parkin DR; Malejka-Giganti D; Hewer A; Phillips DH; Carmichael PL; Gamboa da Costa G; Marques MM
    J Natl Cancer Inst; 2004 Jul; 96(14):1099-104. PubMed ID: 15265972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of a new clinically relevant antiestrogen (GW5638) related to tamoxifen on breast and endometrial cancer growth in vivo.
    Dardes RC; O'Regan RM; Gajdos C; Robinson SP; Bentrem D; De Los Reyes A; Jordan VC
    Clin Cancer Res; 2002 Jun; 8(6):1995-2001. PubMed ID: 12060645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of the mechanism of tamoxifen-stimulated breast tumor growth with nonisomerizable analogues of tamoxifen and metabolites.
    Wolf DM; Langan-Fahey SM; Parker CJ; McCague R; Jordan VC
    J Natl Cancer Inst; 1993 May; 85(10):806-12. PubMed ID: 8487325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 4-Hydroxylated metabolites of the antiestrogens tamoxifen and toremifene are metabolized to unusually stable quinone methides.
    Fan PW; Zhang F; Bolton JL
    Chem Res Toxicol; 2000 Jan; 13(1):45-52. PubMed ID: 10649966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of a 7,12-dimethylbenz[a]anthracene DNA adduct in rat mammary tissue in vivo when pretreated with tamoxifen.
    Warshawsky D; Dowty HV; LaDow K; Succop P; Talaska G
    Toxicol Lett; 2002 Jun; 132(1):71-9. PubMed ID: 12084622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation of oligodeoxynucleotides containing a diastereoisomer of alpha-(N(2)-2'-deoxyguanosinyl)tamoxifen by phosphoramidite chemical synthesis.
    Santosh Laxmi YR; Suzuki N; Dasaradhi L; Johnson F; Shibutani S
    Chem Res Toxicol; 2002 Feb; 15(2):218-25. PubMed ID: 11849048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.